Sort   by:  
 Page size 
To identify the substrates of deubiquitinase USP13, we used a protein label-free quantitation technique, which involves mass spectrometry analysis of peptides from protein digests using liquid chromatography, to identify candidate substrates of USP13 that interact with it from co-immunoprecipitation...
ORGANISM(S): Homo sapiens (Human) 
2025-12-08 | PXD056804 | Pride
To identify the substrates of deubiquitinase USP13, we used a protein label-free quantitation technique, which involves mass spectrometry analysis of peptides from protein digests using liquid chromatography, to identify candidate substrates of USP13 that interact with it from co-immunoprecipitation...
ORGANISM(S): Homo sapiens (Human) 
2025-12-08 | PXD056840 | Pride
USP13 is significantly amplified in over 20% of lung cancer patients and critical for tumor progression. However, the functional role of USP13 in small cell lung cancer (SCLC) remains largely unclear. In this study, we found that the deubiquitinase USP13 is highly expressed in SCLC tumor samples and...
ORGANISM(S): Homo Sapiens 
2022-04-06 | PXD032993 |
USP13 Promotes Deubiquitination of ZHX2 and Tumorigenesis in Kidney Cancer
USP13 Drives Lung Squamous Cell Carcinoma via Switching Lung Club Cell Lineage Plasticity
Clear cell renal cell carcinoma (ccRCC) is characterized by loss of tumor suppressor Von Hippel Lindau (VHL) function. VHL is the component of E3 ligase complex that promotes the ubiquitination and degradation of hypoxia inducible factor alpha (including HIF1alpha and HIF2alpha) and Zinc Fingers And...
ORGANISM(S): Homo sapiens 
2022-07-27 | GSE186717 | GEO
Lung squamous cell carcinoma (LUSC) is associated with high mortality and limited targeted therapies. USP13 is one of the most amplified genes in LUSC, and yet its role in lung cancer is largely unknown. Here, we establish a novel mouse model of LUSC by overexpressing USP13 in KrasG12D/+; Trp53flox/...
ORGANISM(S): Mus musculus 
2024-01-02 | GSE244847 | GEO
Sort   by:  
 Page size